views
RootsAnalysis is pleased to announce the publication of its recent study, titled,“Global Preventive Vaccines Market, 2021-2030”.
Thereport features an extensive study of the current market landscape and futureopportunities associated with the preventive vaccine domain. The study also featuresa detailed analysis of the key drivers and trends related to this evolvingsegment of the pharmaceutical industry. Amongst other elements, the reportincludes:
· A detailed assessment of the current marketlandscape, featuring clinical-stage preventive vaccines.
· A competitiveness analysis of preventivevaccine developers, featuring insightful pictorial summaries andrepresentations.
· Elaborate profiles of the key preventivevaccine developers (shortlisted based on a proprietary criterion) across NorthAmerica, Europe and Asia Pacific.
· An in-depth analysis of the completed,ongoing and planned trials of various preventive vaccines.
· An overview of the ongoing vaccinedevelopment initiatives for complex conditions, such as COVID-19, Ebola virusdisease, HIV/AIDS, malaria and zika virus infection.
· An analysis of the investments made in thisdomain, during the period between 2015 and 2020 (till March).
· A case study on contract manufacturinglandscape for vaccines, featuring the CMOs engaged in this domain.
Knowmore: https://www.rootsanalysis.com/reports/view_document/preventive-vaccines/318.html
Adetailed market forecast, featuring analysis of the current and projectedfuture opportunity across key market segments (listed below)
Routeof Administration
· Intramuscular
· Subcutaneous
· Oral
· Intravenous
· Others
Typeof Vaccine
· Pneumococcal Conjugate Vaccine
· Human Papilloma Virus Vaccine
· Rotavirus Vaccine
· Influenza Vaccine
· MMR Vaccine
· Tetanus and Diphtheria Booster Vaccine
· Varicella Vaccine
· DTaP-Hib-IPV Vaccine
· DTaP-HepB-Hib-IPV Vaccine
· Others
Getan Exclusive Sample PDF @ https://www.rootsanalysis.com/reports/318/request-sample.html
Typeof Vaccine API
· Live, Attenuated Vaccine
· Inactivated Vaccine
· Conjugate Vaccine
· Subunit Vaccine
· Toxoid Vaccine
· Others
TargetPatient Population
· Pediatric Patients
· Adults
KeyPlayers
· GlaxoSmithKline
· Merck
· Sanofi Pasteur
· Pfizer
· Emergent BioSolutions
· CSL
· Others
KeyGeographical Regions
· North America
· Europe
· Asia Pacific
· Rest of the World
Keycompanies covered in the report
· Bio Farma
· Emergent BioSolutions
· GC Pharma
· GlaxoSmithKline
· Janssen
· Merck
· Novavax
· Pfizer
· Sanofi Pasteur
· Valneva
Tableof Contents
1. Preface
2. Executive Summary
3. Introduction
4. MarketLandscape
5. Company Competitiveness Analysis
6. Company Profiles
7. Clinical Trial Analysis
8. Ongoing Vaccine Development Initiatives for ComplexConditions
9. Funding and Investment Analysis
10. Market Sizing and Opportunity Analysis
11. Case-in-Point: Contract Manufacturing of Vaccines
12. Concluding Remarks
13. Executive Insights
14. Appendix 1: Tabulated Data
15. Appendix 2: List ofCompanies and Organizations
EnquiryBefore Purchase:
https://www.rootsanalysis.com/reports/318/request-customization.html
AlsoVisit Our Latest Publication
In Silico / Computer-Aided DrugDiscovery Services Market
Antibody Contract Manufacturing Market
Biopharma Contract Manufacturing Market
Cell Therapy Manufacturing Market
AboutRoots Analysis
RootsAnalysis is one of the fastest growing marketresearch companies, sharing fresh and independent perspectives in thebio-pharmaceutical industry. The in-depth research, analysis and insights aredriven by an experienced leadership team which has gained many years ofsignificant experience in this sector. If you’d like help with your growingbusiness needs, get in touch at info@rootsanalysis.com
ContactInformation
RootsAnalysis Private Limited
GauravChaudhary
+1(415) 800 3415